摘要：肛门、直肠疾病是患者难言之苦,我科于1998年9月1日至1999年2月26日,共治疗388例痔疮,全部采用美宝、CO2激光,创造高超最新技术,解除疾苦,给患者带来美好的福音。

摘要：目的以"原位再生医疗技术治疗糖尿病足"(MEBO-DFU)的规范化流程作为临床应用研究基础,对MEBO-DFU原位再生终止截肢关键节点(Key Nodes,KN)的机制进行辨析,为临床应用理清思路。方法临床总结发现,每个MEBO-DFU规范应用原位再生医疗技术治疗的关键节点都是在对应关键控制点(Critical Control Point,CCP)的掌控下实施的,关键节点的相互连接保障了原位再生医疗技术的临床效果,终止了DFU的截肢手术,实现了创面的原位再生愈合。结果 MEBO-DFU为创面的原位再生创造了生理生态条件,通过溃疡创面的原位再生保留了已坏死的肢、趾,且复发率低,这些效果决定于各个关键节点的正确掌控与实施。结论把握好MEBO-DFU终止截肢的关键节点和与之对应的关键控制点,既是严格规范的原位再生医疗技术实现MEBO-DFU终止截肢与创面原位再生的基础,也是MEBO-DFU规范应用、保障疗效、制定可行治疗规范程序的依据。

摘要：Anal fissure is a common complication of the anorectal region and one of the most reported causes of anal pain. Acute anal fissure can be cured by surgery or medical treatment. There is an increase in the use of topical therapy for the treatment of anal fissures. A common topical drug used is Diltiazem (DTZ), a calcium-channel blocker, which relaxes the anal sphincter and thus promotes healing of the anal fissure. Moist exposed burn ointment (MEBO) is an ointment that is effective for the treatment of burns and wound healing and is becoming popular in the treatment of anal fissures.

摘要：One hundred and thirty-eight (138) patients, with five hundred and sixty-six (566) different burn sites with different degrees, severity and locations, were enrolled to a multicenter clinical trial at 25 study centers. The goal of this trial was to evaluate the efficacy of MEBO (Moist Exposed Burn Ointment) in the treatment of burn wound. Various parameters were studied including: (i) healing time, (ii) need for pain killers, (iii) consumption of i. v. Fluids, (iv) use of systemic antibiotics and (v) aesthetic appearance. There was remarkable decrease in the healing time and most patients either did not need any pain killer or were relieved with only mild analgesics, except in few cases of deep second degree and third degree burns. A decrease in the volume of i. v. fluids needed was also reported. Only 19% of cases developed clinical infection, especially in those who were not treated with MEBO immediately post burn. Even though systemic antibiotic treatment was prophylactically implemented in most cases as a routine measure, 32 cases did not receive any antibiotic prophylaxis with MEBO and yet did not develop any infection. The aesthetic appearance reported was very acceptable. This treatment modality was not associated with any side effects, and patient discomfort during application and change was negligible. Thus, MEBO treatment was associated with excellent and relatively faster healing, low incidence of wound infection, and excellent patient compliance.